ARWR — ARROWHEAD PHARMACEUTICALS IN

Ownership history in WEALTH EFFECTS LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which WEALTH EFFECTS LLC reported a position in ARROWHEAD PHARMACEUTICALS IN (ARWR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.02% (2021 Q4)
Avg. % of fund
2.24%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 143,300 -25,150 -14.9% 2.98% $9.5M $66.39
2025 Q3 ADDED 168,450 +2,800 +1.7% 1.87% $5.8M $34.49
2025 Q2 REDUCED 165,650 -4,900 -2.9% 0.98% $2.6M $15.80
2025 Q1 ADDED 170,550 +14,675 +9.4% 0.91% $2.2M $12.74
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARWR price (monthly, adj. close)

Other funds also holding ARWR

As of 2025 Q4 — sorted by position size

Western Financial Corp/CA 3Y 21.6% Avoro Capital Advisors LLC 3Y 7Y 6.93% Privium Fund Management B.V. 3Y 4.87% M28 Capital Management LP 3Y 3.25% Siren, L.L.C. 2.97% Slate Path Capital LP 3Y 7Y 2.26% Vestal Point Capital, LP 2.03% Exome Asset Management LLC 1.58% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.55% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 1.37%
← Back to WEALTH EFFECTS LLC Holdings